About this product

Product Identifiers

PublisherOxford University Press, Incorporated

ISBN-10019852997X

ISBN-139780198529972

eBay Product ID (ePID)12068262350

Product Key Features

Number of Pages256 Pages

Publication NameEconomic Evaluation in Clinical Trials

LanguageEnglish

Publication Year2007

SubjectClinical Medicine, Public Health, Health Care Delivery

TypeTextbook

Subject AreaMedical

AuthorHenry A. Glick, Seema S. Sonnad, Jalpa A. Doshi, Daniel Polsky

SeriesHandbooks in Health Economic Evaluation Ser.

FormatPerfect

Dimensions

Item Height0.6 in

Item Weight14.1 Oz

Item Length9.2 in

Item Width6.1 in

Additional Product Features

Intended AudienceScholarly & Professional

LCCN2006-035981

Reviews...a straight-forward guide to a not-so-straightforward topic. The book illustrates the difference between 'hard' sciences like chemistry with 'one answer' and 'soft' sciences like economics with 'many answers.' It is essential reading for anyone who wants to know a) how to find a good, maybe even the right, answer, b) how to find the answer that meets the marketing department's needs, and c) how to find the holes in the answer you have been given to get a product into your formulary. Economic evaluation in clinical trials is clearly an area where knowledge is power.

Dewey Edition23

IllustratedYes

Dewey Decimal610.72/4

Table Of Content1. Introduction2. Designing economic evaluations in clinical trials3. Valuing medical service use4. Assessing quality-adjusted life years5. Analyzing cost6. Analyzing censored cost7. Comparing cost and effect: point estimates for cost-effectiveness ratios and net monetary benefit8. Understanding sampling uncertainty: the concepts9. Sampling uncertainty: calculation, sample size and power, and decision criteria10. Evaluating transferability of the results from trials11. Relevance of trial-based economic analyses

SynopsisIt is increasingly important to examine the relationship between the outcomes of a clinical trial and the costs of the medical therapy under study. The results of such analysis can affect reimbursement decisions for new medical technologies, for example drugs, devices or diagnostics; aid companies seeking to make claims about the cost-effectiveness of their product; allow early consideration of the economic value of therapies, which may be important to improving initial adoption decisions; or address the requirements of regulatory bodies. Economic Evaluation in Clinical Trials uses a consistent set of data collected within the trial, or by projection from this data, and avoids having to incorporate unrelated (and potentially inconsistent) data from many different sources. This book provides a practical guide to conducting economic evaluation in ongoing clinical trials. It covers issues and techniques related to the collection of both cost and outcome data, as well as a framework for reporting and interpreting economic reports from clinical trials. This is illustrated by detailed supporting examples and exercises, designed to teach the reader how to apply this model. These exercises are supported with datasets, programmes and solutions made available online., It is becoming increasingly important to examine the relationship between the outcomes of a clinical trial and the costs of the medical therapy under study. The results of such analysis can affect reimbursement decisions for new medical technologies, for example drugs, devices or diagnostics; aid companies seeking to make claims about the cost-effectiveness of their product; allow early consideration of the economic value of therapies, which may be important to improving initial adoption decisions; or address the requirements of regulatory bodies. Economic evaluation in clinical trials uses a consistent set of data collected within the trial, or by projection from this data, and avoids having to incorporate unrelated (and potentially inconsistent) data from many different sources. This book provides a practical guide to conducting economic evaluation in ongoing clinical trials. It covers issues and techniques related to the collection of both cost and outcome data, as well as a framework for reporting and interpreting economic reports from clinical trials. This is illustrated by detailed supporting examples and exercises, designed to teach the reader how to apply this model. These exercises are supported with datasets, programmes and solutions made available online. ABOUT THE SERIES - series editors Alastair Gray and Andrew Briggs Economic evaluation of health intervention is a growing specialist field, and this series of practical handbooks tackles, in depth, topics superficially addressed in more geinconsistent economics books. Each volume includes illustrative material, case histories and worked examples to encourage the reader to apply the methods discussed, with supporting material provided online. This series is aimed at health economists in academia, the pharmaceutical industry and the health sector, those on advanced health economics courses, and health researchers in associated fields., It is increasingly important to examine the relationship between the outcomes of a clinical trial and the costs of the medical therapy under study. This book provides a practical guide to the techniques and issues involved in conducting economic evaluation in ongoing clinical trials, supported with detailed examples., It is becoming increasingly important to examine the relationship between the outcomes of a clinical trial and the costs of the medical therapy under study. The results of such analysis can affect reimbursement decisions for new medical technologies, for example drugs, devices or diagnostics; aid companies seeking to make claims about the cost-effectiveness of their product; allow early consideration of the economic value of therapies, which may be important to improving initial adoption decisions; or address the requirements of regulatory bodies. Economic evaluation in clinical trials uses a consistent set of data collected within the trial, or by projection from this data, and avoids having to incorporate unrelated (and potentially inconsistent) data from many different sources. This book provides a practical guide to conducting economic evaluation in ongoing clinical trials. It covers issues and techniques related to the collection of both cost and outcome data, as well as a framework for reporting and interpreting economic reports from clinical trials. This is illustrated by detailed supporting examples and exercises, designed to teach the reader how to apply this model. These exercises are supported with datasets, programmes and solutions made available online.ABOUT THE SERIES - series editors Alastair Gray and Andrew BriggsEconomic evaluation of health intervention is a growing specialist field, and this series of practical handbooks tackles, in depth, topics superficially addressed in more general health economics books. Each volume includes illustrative material, case histories and worked examples to encourage the reader to apply the methods discussed, with supporting material provided online. This series is aimed at health economists in academia, the pharmaceutical industry and the health sector, those on advanced health economics courses, and health researchers in associated fields.

LC Classification NumberQV 771E19 2007